Core C provides essential support for the generation and characterization of mouse mosaic models by Program investigators. The models supported by the Core include a myc-induced lymphoma model, a mosaic model of hepatocellular carcinoma, and a mosaic model of mammary carcinoma - all three of which are were developed by Program investigators and are used throughout the Program. The Core will maintain a series of animal colonies that provide a source of progenitor cells or recipient animals for the production of mouse mosaics. It will also isolate hematopoietic, liver, and mammary progenitor cells using protocols established by the Program for use by individual Projects, and train and assist Project investigators in the generation of mouse mosaics and in monitoring of tumorigenesis. Finally, the Core incorporates a highly skilled pathologist and histology service to enable a detailed characterization of various pathological phenotypes. These services bring to the Program unique, high quality, and cost effective services that enable each Project to effectively use in vivo models to probe various aspects of normal and tumor biology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA013106-38
Application #
7784564
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-01-01
Budget End
2009-12-31
Support Year
38
Fiscal Year
2009
Total Cost
$408,039
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
On, Kin Fan; Jaremko, Matt; Stillman, Bruce et al. (2018) A structural view of the initiators for chromosome replication. Curr Opin Struct Biol 53:131-139
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554:378-381
Shamay, Yosi; Shah, Janki; I??k, Mehtap et al. (2018) Quantitative self-assembly prediction yields targeted nanomedicines. Nat Mater 17:361-368
Tramentozzi, Elisa; Ferraro, Paola; Hossain, Manzar et al. (2018) The dNTP triphosphohydrolase activity of SAMHD1 persists during S-phase when the enzyme is phosphorylated at T592. Cell Cycle 17:1102-1114
Arun, Gayatri; Diermeier, Sarah D; Spector, David L (2018) Therapeutic Targeting of Long Non-Coding RNAs in Cancer. Trends Mol Med 24:257-277
Tarumoto, Yusuke; Lu, Bin; Somerville, Tim D D et al. (2018) LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia. Mol Cell 69:1017-1027.e6
Xu, Yali; Milazzo, Joseph P; Somerville, Tim D D et al. (2018) A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. Cancer Cell 33:13-28.e8
Huang, Yu-Han; Klingbeil, Olaf; He, Xue-Yan et al. (2018) POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev 32:915-928
Livshits, Geulah; Alonso-Curbelo, Direna; Morris 4th, John P et al. (2018) Arid1a restrains Kras-dependent changes in acinar cell identity. Elife 7:
Tiriac, Hervé; Belleau, Pascal; Engle, Dannielle D et al. (2018) Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov 8:1112-1129

Showing the most recent 10 out of 610 publications